East West Bancorp vs M&T Bank
EWBC and MTB side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EWBC and MTB compare
M&T Bank is the larger company, worth 1.8 times as much as East West Bancorp ($31.9B against $18.0B).
On earnings, M&T Bank is cheaper: it trades at 11.5× trailing earnings, against 12.5× for East West Bancorp.
East West Bancorp grew revenue faster over the last twelve months (10.4% versus 5.5% for M&T Bank).
M&T Bank keeps more of each dollar of sales as profit, with a net margin of 176% compared with 46.4% at East West Bancorp.
Both pay dividends: East West Bancorp yields 2.4% and M&T Bank 2.7%.
M&T Bank scores higher on the StockData Score (17 against 14 for East West Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EWBC | MTB |
|---|---|---|
| Size and price | ||
| Market cap | $18.0B | $31.9B |
| Share price | $131.21 | $221.12 |
| Change, 1 year | 24.5% | 17.5% |
| Change, 5 years | 61.6% | 40.5% |
| Beta (5Y) | 1.10 | 0.82 |
| Employees | 3,350 | 22K |
| StockData Score | ||
| Total score | 14 | 17 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 6 (better) | 4 |
| Health score | 6 | 6 |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/E | 12.5× | 11.5× (better) |
| P/S | 5.7× (better) | 18.6× |
| P/B | 2.0× | 1.1× (better) |
| PEG | 1.97 | 0.84 (better) |
| Fair value | $110.59 | $231.26 |
| Margin of safety | −18.6% | 4.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 10.4% (better) | 5.5% |
| Revenue growth, 5Y average | 12.7% (better) | −22.6% |
| Net income growth (TTM) | 15.7% (better) | 8.8% |
| EPS growth (TTM) | 16.1% | 18.0% (better) |
| EPS growth, 5Y average | 19.1% (better) | 11.3% |
| Profitability | ||
| Net margin | 46.4% | 176% (better) |
| Return on equity | 16.6% (better) | 10.6% |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.23 |
| Altman Z-score | 0.32 (better) | 0.25 |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | 2.4% | 2.7% (better) |
| Payout ratio | – | 29.5% |
| Years of dividend growth | 8 (better) | 3 |
| Dividend growth, 5Y average | 16.9% | – |
| Buyback yield | 0.55% | 7.9% (better) |
| Shareholder yield | 3.0% | 10.6% (better) |
| Ownership | ||
| Held by institutions | 92.3% | 91.4% |
| Held by insiders | 0.76% | 0.36% |
| Insider net buying, 12 months | −$30.6M | −$24.7M (better) |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 3.4% | 3.4% |
Go deeper
- EWBC stock overview
- EWBC income statement
- EWBC valuation and score
- MTB stock overview
- MTB income statement
- MTB valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.